ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Sai Parenterals reported no deviation or variation in the utilization of IPO proceeds for the quarter ended June 30, 2026. This is a routine compliance filing.
Sai Parenterals Ltd submitted its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulatory requirements.
Sai Parenterals Ltd has submitted its quarterly shareholding pattern for the period ended June 30, 2026, as required by SEBI regulations.
Sai Parenterals Ltd has announced a delay in submitting its financial results for the quarter and nine months ended December 31, 2025. The delay is due to the pending audit of its recently acquired Australian subsidiary, Noumed Pharmaceuticals PTY Limited. The company expects to submit the results by May 15, 2026.
Sai Parenterals Ltd has updated its list of Key Managerial Personnel authorized to determine event materiality and make stock exchange disclosures. The authorized persons include the Managing Director, CFO, and Company Secretary. This is a routine regulatory update under SEBI Listing Regulations.